|
CRON | Cronos Group Inc. |
|
|
CRON | Cronos Group Inc. |
| Medicinal Chemicals & Botanical Products |
| Book value per $ invested | $ 1.48 |
| Leverage | 4.74% |
| Market Cap | $ 751.2m |
| PE | 18.71 |
| Dividend Yield | 0.00% |
| Profit | $ 40.1m |
| Margin | 34.42% |
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.